Malaysian Genomics Resource Centre Berhad (“MGRC” or “the Group”), a leading genomics and biopharmaceutical specialist, is pleased to announce that their wholly-owned subsidiary MGRC Therapeutics Sdn Bhd (“MGRCT”) has entered a Memorandum of Understanding (“MoU”) with Twistcode Technologies Sdn Bhd (“Twistcode Technologies”). This collaboration will focus on the Bioinformatics Enhanced-Accelerated Services Terminal (B.E.A.S.T), a cutting-edge platform designed to revolutionise bioinformatics services across Malaysia and the Middle East.
Under the terms of the MoU, MGRCT and Twistcode Technologies will explore collaborative opportunities in research, development, and commercialisation. The partnership is poised to develop advanced bioinformatics tools and integrate artificial intelligence to accelerate bioinformatics processes, ultimately fostering a one-stop solution for bioinformatics services.
Azri Azerai, Executive Chairman of Malaysian Genomics expressed his enthusiasm about the collaboration by saying, "We are thrilled to partner with Twistcode Technologies to leverage their expertise in supercomputing and AI. This collaboration is set to enhance our capabilities in genomics and biopharmaceuticals significantly. Together, we aim to set new benchmarks in bioinformatics, contributing to advancements in healthcare and precision medicine."
Nurazam Malim, Chief Executive Officer of Twistcode Technologies said, "This MoU with MGRCT marks a significant milestone in our journey to harness the power of AI in healthcare. The B.E.A.S.T platform represents a major step forward in our commitment to innovation and excellence. We are confident that this collaboration will not only enhance our technological capabilities but also create substantial value for the bioinformatics community."
This strategic collaboration highlights MGRC’s commitment to spearheading innovation and transforming healthcare outcomes through advanced biotechnologies. By combining MGRC’s healthcare production capabilities with Twistcode Technologies' computational expertise, this partnership is set to significantly advance the reach and effectiveness of bioinformatics services.
